Nutex Health Announces Agreement With MeMed To Adopt Pioneering MeMed BV Test Across Its Network Of 19 Sites
Portfolio Pulse from Happy Mohamed
Nutex Health (NASDAQ:NUTX) has announced a strategic partnership with MeMed to adopt the MeMed BV test across its network of 19 sites. The FDA-cleared technology distinguishes viral from bacterial infections in 15 minutes, helping physicians make better informed antibiotic treatment decisions.
May 25, 2023 | 12:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nutex Health's partnership with MeMed to adopt the MeMed BV test across its 19 sites will enhance patient management and improve antibiotic treatment decisions.
The partnership with MeMed will allow Nutex Health to provide better healthcare services by distinguishing viral from bacterial infections in 15 minutes. This will help physicians make better informed antibiotic treatment decisions, improving patient outcomes and potentially attracting more patients to Nutex Health's network.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100